Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion description "[Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion evidence source_evidence_literature NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion SIO_000772 24059322 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion wasDerivedFrom befree-2016 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion wasGeneratedBy ECO_0000203 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.